by McDermott + Bull | Sep 10, 2024 | Healthcare + Life Sciences, Healthcare + Life Sciences Placement Announcement, Ken Dropiewski, Ken Dropiewski Placement Announcement, Paul Gibbons, Paul Gibbons Placement Announcement, Placement Announcement
McDermott + Bull has successfully placed Helen Routh and Beverly Huss as members of the Board of Directors at Clarius Mobile Health. They will bring their vast expertise in healthcare technology and medical devices to help Clarius continue to innovate and grow. Their...
by McDermott + Bull | Sep 3, 2024 | Healthcare + Life Sciences, Healthcare + Life Sciences Placement Announcement, Jake Vander Zanden, Jake Vander Zanden Placement Announcement, Michael Matranga, Placement Announcement
McDermott + Bull has successfully placed Scott Corning as Vice President, Americas at Rayner Surgical Group Ltd. Scott will play a pivotal role in developing and executing the company’s strategic initiatives, including driving growth and profitability across Canada,...
by McDermott + Bull | Sep 3, 2024 | Placement Announcement, Adrian Rufo, Healthcare + Life Sciences, Healthcare + Life Sciences Placement Announcement, Jake Vander Zanden, Jake Vander Zanden Placement Announcement, Michael Matranga
McDermott + Bull has successfully placed James Hopper as Senior Director, Business Development at TSTrials. Headquartered in Buenos Aires, Argentina, James will execute TSTrials’ global growth strategy, focused on leading business development, fostering existing...
by McDermott + Bull | Jun 25, 2024 | Healthcare + Life Sciences, Healthcare + Life Sciences Article, Ken Dropiewski, Ken Dropiewski Article, Technology Article
The JPM Q1 2024 MedTech Licensing and Venture report highlights the first quarter of 2024 and shows promising developments in the MedTech investment landscape. There are indications of a potential recovery and growth compared to previous years. Can we be so lucky?...
by McDermott + Bull | May 31, 2024 | Healthcare + Life Sciences, Healthcare + Life Sciences Placement Announcement, Ken Dropiewski, Ken Dropiewski Placement Announcement, Michael Matranga, Placement Announcement
McDermott + Bull has successfully placed Tom Mock as the Director of Research and Development at NVMedTech. Tom will oversee the completion of one of the company’s main intravascular products, managing its design finalization, initiating GLP animal studies, and...
by McDermott + Bull | May 22, 2024 | Article, Garrett Lipus, Garrett Lipus Article, Healthcare + Life Sciences, Healthcare + Life Sciences Article, Lipus
Healthcare PE activity in Q1 2024 remained subdued, marking a continuation of the downturn seen in 2023. PE sponsors announced or closed an estimated 158 deals in the quarter, maintaining the sluggish pace of 2023. Despite a somewhat more optimistic narrative around...
